Author:
Abbaszadeh Hamid,Kabiri-Rad Hamid,Mohammadi Fariba,Zangoie Soheila,Rajabi-Moghaddam Mahdieh,Ghafari Shokouh,Ziaee Masood,Javanmard Davod,Miri-Moghaddam Ebrahim
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Bakhshandeh B, Sorboni SG, Javanmard A-R, Mottaghi SS, Mehrabi M-R, Sorouri F, Abbasi A, Jahanafrooz Z (2021) Variants in ACE2; potential influences on virus infection and COVID-19 severity. Infect Genet Evol 90:104773
2. Chan KA, Tang NL, Hui DS, Chung GT, Wu AK, Chim SS, Chiu RW, Lee N, Choi K, Sung YM (2005) Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study. BMC Infect Dis 5:1–6
3. Chaoxin J, Daili S, Yanxin H, Ruwei G, Chenlong W, Yaobin T (2013) The influence of angiotensin-converting enzyme 2 gene polymorphisms on type 2 diabetes mellitus and coronary heart disease. European Review for Medical & Pharmacological Sciences, p 17
4. Coates D (2003) The angiotensin converting enzyme (ACE). Int J Biochem Cell Biol 35:769–773
5. Delanghe JR, De Buyzere ML, Speeckaert MM (2020) ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism. Eur J Prev Cardiol 27:1331–1332